Literature DB >> 19754767

Orbitomaxillary mucormycosis (zygomycosis) and the surgical approach to treatment: perspectives from a maxillofacial surgeon.

A D Rapidis1.   

Abstract

Rhinocerebral or rhino-orbitocerebral (mucormycosis) zygomycosis (ROCZ) usually occurs among patients with poorly controlled diabetes mellitus (especially those with ketoacidosis), solid malignancies, iron overload or extensive burns, in patients undergoing treatment with glucocorticosteroid agents, or in patients with neutropenia related to haematologic malignancies. The disease process starts with inhalation of the fungus into the paranasal sinuses. The fungus may spread to invade the palate, sphenoid sinus, cavernous sinus, orbits or cranially to invade the brain. Pain and swelling precede oral ulceration and the resulting tissue necrosis can result in palatal perforation. Infection can sometimes extend from the sinuses into the mouth and produce painful, necrotic ulcerations of the hard palate. If untreated, infection usually spreads from the ethmoid sinus to the orbit, resulting in the loss of extraocular muscle function and proptosis. Surgical treatment includes the resection of involved tissues of the face, including skin and muscle, any skin of the nose that is involved, maxillary and ethmoid sinuses, necrotic tissue of the temporal area and infratemporal fossa, and orbital exenteration. The keys to successful therapy include suspicion of the diagnosis and early recognition of the signs and symptoms, correction of underlying medical disorders such as ketoacidosis, and aggressive medical and surgical intervention.

Entities:  

Mesh:

Year:  2009        PMID: 19754767     DOI: 10.1111/j.1469-0691.2009.02989.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  18 in total

1.  Extranodal natural killer/T cell lymphoma, nasal type presenting as a palatal perforation and naso-oral fistula.

Authors:  Vijaya Raj Bhatt; Bibek Koirala; Terenig Terjanian
Journal:  BMJ Case Rep       Date:  2011-03-01

2.  Burn injuries and soft tissue traumas complicated by mucormycosis infection: a report of six cases and review of the literature.

Authors:  E J Kyriopoulos; A Kyriakopoulos; A Karonidis; A Gravvanis; I Gamatsi; C Tsironis; D Tsoutsos
Journal:  Ann Burns Fire Disasters       Date:  2015-12-31

3.  Importance of immediate surgical intervention and antifungal treatment for rhinocerebral mucormycosis: a case report.

Authors:  Jin-Geun Kim; Hye Jeong Park; Jung Hyun Park; Jiwoong Baek; Hyung Jun Kim; In-Ho Cha; Woong Nam
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2013-10-22

4.  Invasive fatal rhino-orbito-cerebral mucormycosis in diabetic ketoacidosis.

Authors:  George Garas; Natasha Choudhury; Roy Farrell
Journal:  JRSM Short Rep       Date:  2010-12-01

5.  Multimodal surgical and medical treatment for extensive rhinocerebral mucormycosis in an elderly diabetic patient: a case report and literature review.

Authors:  Paola Di Carlo; Roberto Pirrello; Giuliana Guadagnino; Pierina Richiusa; Antonio Lo Casto; Caterina Sarno; Francesco Moschella; Daniela Cabibi
Journal:  Case Rep Med       Date:  2014-05-27

6.  Successful therapy of progressive rhino-orbital mucormycosis caused by Rhizopus arrhizus with combined and sequential antifungal therapy, surgery and hyperbaric therapy.

Authors:  Adrián Imbernón; José Luis Agud; María Soledad Cuétara; José Carlos Casqueiro; Pilar Nuñez; Alegría R Domínguez; Eusebio Bullido; Alberto M Stchigel
Journal:  Med Mycol Case Rep       Date:  2014-10-05

7.  Guideline for diagnosis, prophylaxis and treatment of invasive fungal infection post burn injury in China 2013.

Authors:  Gaoxing Luo; Jianglin Tan; Yizhi Peng; Jun Wu; Yuesheng Huang; Daizhi Peng; Xu Wang; Dahai Hu; Songtao Xie; Guoan Zhang; Chunmao Han; Xiaoyuan Huang; Ciyu Jia; Jiake Chai; Jingning Huan; Guanghua Guo; Jianhua Zhan; Weiguo Xie; Ying Cen; Rong Yu; Huade Chen; Xihua Niu; Yibing Wang; Jinfeng Fu; Baosheng Xue
Journal:  Burns Trauma       Date:  2014-04-06

8.  Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis.

Authors:  Teclegiorgis Gebremariam; Sondus Alkhazraji; Sameh S M Soliman; Yiyou Gu; Heewon H Jeon; Lina Zhang; Samuel W French; David A Stevens; John E Edwards; Scott G Filler; Priya Uppuluri; Ashraf S Ibrahim
Journal:  Sci Adv       Date:  2019-06-12       Impact factor: 14.136

Review 9.  Mucormycosis in a surgical defect masquerading as osteomyelitis: a case report and review of literature.

Authors:  Ashwini Kumar Mengji; Uday Shankar Yaga; Nishanth Gollamudi; Bhanu Prakash; Edunuri Rajashekar
Journal:  Pan Afr Med J       Date:  2016-01-26

Review 10.  Dental and Oral Manifestations of COVID-19 Related Mucormycosis: Diagnoses, Management Strategies and Outcomes.

Authors:  Omer Sefvan Janjua; Muhammad Saad Shaikh; Muhammad Amber Fareed; Sana Mehmood Qureshi; Muhammad Ikram Khan; Danya Hashem; Muhammad Sohail Zafar
Journal:  J Fungi (Basel)       Date:  2021-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.